Raft Pharmaceuticals is a startup biopharmaceutical company developing novel therapy targeting lipid rafts in inflamed and activated cells. Raft’s product, recombinant protein RFT-001 regulates cholesterol trafficking in the plasma membrane and normalizes clustered and cholesterol-overloaded lipid raft microdomains – specifically in inflamed glia and macrophages, relevant to the development of chronic pain states. Chronic pain is a major health problem affecting 20% of the population and 40% of older adults, having an extraordinary negative impact on quality of life. The annual cost of chronic pain is $635B. Opiates, NSAIDs, and anticonvulsants relieve pain for short intervals, but are less effective for chronic therapy, have serious side effects and potential for diversion and addiction (opioid epidemics). Animal testing shows the unprecedented efficacy of RFT-001 in models of chemotherapy- and nerve injury-induced neuropathic pain, as well as migraine.
View Top Employees from Raft PharmaceuticalsWebsite | https://raftpharma.com |
Revenue | $1 million |
Employees | View employees |
Founded | 2018 |
Address | 10225 Barnes Canyon Rd STE A104, San Diego, California 92121, US |
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
Competitors | Confluence Life Sciences, Immunohelix, Vapogenix, Inc., Winston Laboratories |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Raft Pharmaceuticals employee's phone or email?
The Raft Pharmaceuticals annual revenue was $1 million in 2024.
Raft Pharmaceuticals is based in San Diego, California.
The NAICS codes for Raft Pharmaceuticals are [325, 32541, 32, 3254].
The SIC codes for Raft Pharmaceuticals are [283, 28].